Sergio L Schmidt,1,2 Michele Santos da Silva,2 Juliana J Schmidt,2 Ana Lucia Novais Carvalho,3 Claudia Cristina Ferreira Vasconcelos,2 Renata Alves Paes,2 Yolanda EM Boechat,4 Rafael Neder,2 Regina P Alvarenga2 1Department of Neurophysiology, State University of Rio de Janeiro, RJ, Brazil; 2Neurology Department, Federal University of the State of Rio de Janeiro, RJ, Brazil; 3Department of Psychology, Fluminense Federal University, Niteroi, Brazil; 4Department of Internal Medicine, Fluminense Federal University, Niteroi, Brazil Background: In the early phases of multiple sclerosis (MS), patients exhibit slight neuropsychiatric deficits that can only be detected using reliable tools. Aim: The present investigation aimed to examine neu...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Forty mildly disabled and clinically stable patients with multiple sclerosis (MS), representative of...
The correlation between the pathological changes of multiple sclerosis and the subcortical dementia ...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Primary objective: The cognitive profile of patients with Multiple Sclerosis in the Brazilian popula...
Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
The aim of this thesis was to extend previous studies that have attempted to relate neuropsychologic...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
To investigate the neuropsychological profile in the first few years post-onset of relapsing/remitti...
To assess the cognition of patients with multiple sclerosis (MS) using the Rao's Brief Repeatable Ba...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Forty mildly disabled and clinically stable patients with multiple sclerosis (MS), representative of...
The correlation between the pathological changes of multiple sclerosis and the subcortical dementia ...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Primary objective: The cognitive profile of patients with Multiple Sclerosis in the Brazilian popula...
Objective. The aim of our study was to investigate the frequency and pattern of cognitive impairment...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
The aim of this thesis was to extend previous studies that have attempted to relate neuropsychologic...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
To investigate the neuropsychological profile in the first few years post-onset of relapsing/remitti...
To assess the cognition of patients with multiple sclerosis (MS) using the Rao's Brief Repeatable Ba...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients w...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Forty mildly disabled and clinically stable patients with multiple sclerosis (MS), representative of...
The correlation between the pathological changes of multiple sclerosis and the subcortical dementia ...